Windham Venture Partners

Windham Venture Partners, founded in 2006 and headquartered in New York City, focuses on early-stage investments in the healthcare sector, particularly in medical technology, digital health, and life sciences. The firm is dedicated to investing in companies that bring significant advancements and innovations in healthcare, emphasizing transformative impact and commercialization of cutting-edge technologies. Their notable investments include companies like Alto Neuroscience, Valera Health, and SubjectWell. Windham Venture Partners has achieved successful exits with companies such as CVRx, which went public, and SubjectWell, acquired by WindRose Health Investors. The firm has made 74 investments and has seen 25 exits, showcasing a robust portfolio and strategic investment approach. Led by co-founders Roger Fine, Adam Fine, and Joseph Proto, Windham Venture Partners brings together a team of experienced professionals dedicated to supporting their portfolio companies with strategic guidance and resources. The firm collaborates with a wide range of co-investors, enhancing its ability to back high-impact ventures and drive innovation in healthcare​.